Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Mogrol-3-o-(beta-d-glucopyranosyl (1-6)-beta-d-glucopyranoside)-24-o-((beta-d-glucopyranosyl (1-2))-(beta-d-glucopyranosyl(1-6))-beta-d-glucopyranoside)
1. 88901-36-4
2. Zff6z51tur
3. Mogrol-3-o-(beta-d-glucopyranosyl (1-6)-beta-d-glucopyranoside)-24-o-((beta-d-glucopyranosyl (1-2))-(beta-d-glucopyranosyl(1-6))-beta-d-glucopyranoside)
4. Refchem:159318
5. (2r,3r,4s,5s,6r)-2-(((2r,3s,4s,5r,6r)-6-(((3s,8s,9r,10r,11r,13r,14s,17r)-17-((2r,5r)-5-((2s,3r,4s,5s,6r)-4,5-dihydroxy-3-((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-6-(((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxymethyl)oxan-2-yl)oxy-6-hydroxy-6-methylheptan-2-yl)-11-hydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1h-cyclopenta(a)phenanthren-3-yl)oxy)-3,4,5-trihydroxyoxan-2-yl)methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
6. Mogroside
7. Mogroside Cento
8. Mfcd00238649
9. Mogroside-v
10. Mogroside V (standard)
11. Unii-zff6z51tur
12. Mogroside V [usp-rs]
13. Orb1304779
14. Schembl4572693
15. Chembl1829228
16. Hy-n0502r
17. Chebi:229959
18. Ghbnzzjybxqahg-kuvsnlsmsa-n
19. Hy-n0502
20. Msk40108
21. S3815
22. Akos037645029
23. Ccg-270667
24. Om09974
25. As-56272
26. Cs-0009025
27. 901m364
28. (1s,4r,9beta,11alpha,24r)-1-{[6-o-(beta-d-glucopyranosyl)-beta-d-glucopyranosyl]oxy}-11,25-dihydroxy-9,10,14-trimethyl-4,9-cyclo-9,10-secocholest-5-en-24-yl Beta-d-glucopyranosyl-(1->2)-[beta-d-glucopyranosyl-(1->6)]-beta-d-glucopyranoside
29. (3.beta.,9.beta.,10.alpha.,11.alpha.,24r)-3-((6-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranosyl)oxy)-11,25-dihydroxy-9-methyl-19-norlanost-5-en-24-yl O-.beta.-d-glucopyranosyl-(1->2)-o-(.beta.-d-glucopyranosyl-(1->6))-.beta.-d-glucopyranoside
30. .beta.-d-glucopyranoside, (3.beta.,9.beta.,10.alpha.,11.alpha.,24r)-3-((6-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranosyl)oxy)-11,25-dihydroxy-9-methyl-19-norlanost-5-en-24-yl O-.beta.-d-glucopyranosyl-(1->2)-o-(.beta.-d-glucopyranosyl-(1->6))-
31. Beta-d-glucopyranoside, (3beta,9beta,10alpha,11alpha,24r)-3-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-11,25-dihydroxy-9-methyl-19-norlanost-5-en-24-yl O-beta-d-glucopyranosyl-(1-2)-o-(beta-d-glucopyranosyl-(1-6))-
32. Mogrol-3-o-(.beta.-d-glucopyranosyl (1-6)-.beta.-d-glucopyranoside)-24-o-((.beta.-d-glucopyranosyl (1-2))-(.beta.-d-glucopyranosyl(1-6))-.beta.-d-glucopyranoside)
| Molecular Weight | 1287.4 g/mol |
|---|---|
| Molecular Formula | C60H102O29 |
| XLogP3 | -3.7 |
| Hydrogen Bond Donor Count | 19 |
| Hydrogen Bond Acceptor Count | 29 |
| Rotatable Bond Count | 20 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 477 |
| Heavy Atom Count | 89 |
| Formal Charge | 0 |
| Complexity | 2360 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 35 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
90
PharmaCompass offers a list of Mogroside V API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mogroside V manufacturer or Mogroside V supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mogroside V manufacturer or Mogroside V supplier.
A Mogroside V manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mogroside V, including repackagers and relabelers. The FDA regulates Mogroside V manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mogroside V API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mogroside V supplier is an individual or a company that provides Mogroside V active pharmaceutical ingredient (API) or Mogroside V finished formulations upon request. The Mogroside V suppliers may include Mogroside V API manufacturers, exporters, distributors and traders.
Mogroside V Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mogroside V GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mogroside V GMP manufacturer or Mogroside V GMP API supplier for your needs.
A Mogroside V CoA (Certificate of Analysis) is a formal document that attests to Mogroside V's compliance with Mogroside V specifications and serves as a tool for batch-level quality control.
Mogroside V CoA mostly includes findings from lab analyses of a specific batch. For each Mogroside V CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mogroside V may be tested according to a variety of international standards, such as European Pharmacopoeia (Mogroside V EP), Mogroside V JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mogroside V USP).
